S PHYLLIN N:Uses, Dosage, Side Effects, Price, Composition, safety,precations and More

S PHYLLIN N

Acebrophylline (100mg), Acetylcysteine (600mg)

S PHYLLIN N combination of Acebrophylline (100mg), Acetylcysteine (600mg), known by the brand name S PHYLLIN N, is a combination medication used in the treatment of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and bronchial asthma. This formulation combines the bronchodilator and mucolytic properties of acebrophylline and acetylcysteine, respectively, to promote bronchial relaxation and mucus clearance. In this article, we delve into the uses, benefits, and mechanism of action of Acebrophylline (100mg), Acetylcysteine (600mg) in enhancing respiratory health.

Understanding Acebrophylline (100mg), Acetylcysteine (600mg):

Acebrophylline is a bronchodilator that works by relaxing the smooth muscles of the bronchial airways, thereby improving airflow and reducing bronchospasm. Acetylcysteine, on the other hand, is a mucolytic agent that helps to break down and liquefy thick mucus, making it easier to expectorate. Together, these two components synergistically alleviate respiratory symptoms and improve lung function.

Key Benefits of Acebrophylline (100mg), Acetylcysteine (600mg):

• Dual Action: This combination medication offers dual benefits of bronchodilation and mucus clearance, targeting different aspects of respiratory dysfunction.
• Improved Airway Clearance: Acetylcysteine helps to thin and loosen mucus secretions, making it easier for patients to cough up and clear their airways.
• Reduced Exacerbations: By promoting bronchial relaxation and mucus clearance, Acebrophylline (100mg), Acetylcysteine (600mg) can help reduce the frequency and severity of COPD exacerbations and asthma attacks.

Clinical Uses of Acebrophylline (100mg), Acetylcysteine (600mg):

• COPD Management: This medication is indicated for the maintenance treatment of COPD, including chronic bronchitis and emphysema, to improve respiratory function and reduce exacerbations.
• Bronchial Asthma: It may also be used as adjunctive therapy in the management of bronchial asthma, particularly in patients with persistent symptoms despite standard treatment.

Dosage and Administration:

• Standard Dosage: The typical dosage of Acebrophylline (100mg), Acetylcysteine (600mg) may vary depending on the severity of the patient's condition and their response to therapy.
• Oral Administration: The medication is usually taken orally, with or without food, as prescribed by a healthcare provider.
• Regular Use: To achieve the full therapeutic benefits, patients are advised to take Acebrophylline (100mg), Acetylcysteine (600mg) regularly and consistently, following the prescribed dosage regimen.

Safety Profile and Precautions:

• Common Side Effects: Common side effects of Acebrophylline (100mg), Acetylcysteine (600mg) may include gastrointestinal discomfort, nausea, vomiting, and diarrhea. 
• Contraindications: This medication is contraindicated in patients with a history of hypersensitivity to any of its components or to xanthine derivatives.
• Drug Interactions: Patients should inform their healthcare provider about all medications they are taking, as certain drugs may interact with Acebrophylline (100mg), Acetylcysteine (600mg) and affect its efficacy or safety.

Conclusion:

Acebrophylline (100mg), Acetylcysteine (600mg), marketed as S PHYLLIN N, is a valuable combination medication for the management of respiratory conditions such as COPD and bronchial asthma. By combining the bronchodilator effects of acebrophylline with the mucolytic action of acetylcysteine, this medication provides comprehensive relief from respiratory symptoms and helps improve lung function. However, it is essential for patients to use Acebrophylline (100mg), Acetylcysteine (600mg) as directed by their healthcare provider and to be aware of potential side effects or drug interactions. Through proper use and monitoring, this medication can play a crucial role in optimizing respiratory health and enhancing the quality of life for individuals with obstructive lung diseases.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information:  

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488
 

BUY NOW